We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Powassan Virus Diagnosed in Patients with Tick-Borne Diseases

By LabMedica International staff writers
Posted on 02 Aug 2017
Powassan virus (POWV) lineage II, also known as deer tick virus, is an emerging tick-borne flavivirus transmitted by Ixodes scapularis ticks, which are also the primary vector for the Lyme disease pathogen Borrelia burgdorferi.

The seroprevalence of POWV in humans in some regions of North America is known with a range of 0.5% to 3.3%, but because the geographic distribution is quite extensive, the seroprevalence of most at-risk populations is uncertain. More...
POWV is typically detected with an immunoglobulin M (IgM) antibody capture e enzyme-linked immunosorbent assay (ELISA) or an IgM immunofluorescence antibody (IFA) assay.

Scientists at the Marshfield Clinic Research Foundation (Minocqua, WI, USA) and their colleagues selected 95patients with suspected tick-borne disease (TBD) and 50 patients undergoing routine chemical screening who sought treatment during July to August 2015 at the Marshfield Clinic in northern Wisconsin, a TBD-endemic area. Patients were considered to have suspected TBD if a serologic test for B. burgdorferi was ordered.

The investigators performed screening assays on all specimens for tick-borne encephalitis virus complex (TBEV-C) and B. burgdorferi and performed POWV serology on TBEV-C–positive specimens. They evaluated heterologous flavivirus cross-reactivity, by performing the West Nile virus (WNV) enzyme immunoassay with TBEV-C–positive samples. They also performed the EUROIMMUN Flavivirus Mosaic Panel, an IgG IFA assay panel including tests for TBEV, WNV, yellow fever virus, dengue viruses 1–4, and Japanese encephalitis virus, on samples positive for POWV IgG by the IFA assay.

Serologic evidence of POWV infection was present in nine (9.5%) TBD patients and two (4.0%) patients with routine chemistry screening completed. Similar to other flavivirus serologic assays, considerable cross-reactivity occurred with the Flavivirus Mosaic IgG IFA assay. The fluorescence intensity was stronger for TBEV than it was for other flaviviruses in all TBD patients except for one patient with prior confirmed WNV infection. Evidence of current or prior B. burgdorferi infection was present in 63 (66.3%) TBD patients. Of the 41 (43.2%) TBD patients with evidence of B. burgdorferi infection, seven (17.1%) had serologic evidence of acute POWV infection and three (7.3%) had laboratory-confirmed POWV infection.

The authors concluded that in a Lyme disease–endemic area, POWV seroreactivity and confirmed POWV infection were present. The spectrum of disease is broader than previously realized, with most patients having minimally symptomatic infection. The study was published in the August 2017 issue of the journal Emerging Infectious Diseases.

Related Links:
Marshfield Clinic Research Foundation



Gold Member
Automatic Hematology Analyzer
CF9600
Online QC Software
Acusera 24•7
New
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
Japanese Encephalitis Test
Japanese Encephalitis Virus Real Time PCR Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The SimpleScreen CRC platform uses multiomics, AI, and machine learning to analyze blood-based signals and detect cancer-associated patterns (Photo courtesy of Freenome)

Blood Test Achieves Improved Detection of Advanced Precancerous Colorectal Lesions

Colorectal cancer is the second-leading cause of cancer-related death in the United States, yet screening uptake remains suboptimal. More than 50 million eligible adults are not up to date with recommended... Read more

Hematology

view channel
Image Credit: Shutterstock

New Biomarkers Predict Resistance to Targeted Therapy in Rare Blood Cancer

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive leukemia with limited treatment options and a poor prognosis. Although tagraxofusp is the first approved targeted therapy for... Read more

Industry

view channel
Photo courtesy of Natera

Natera’s Signatera Earns IVDR Certification for Solid Tumor MRD Testing

Natera’s Signatera has received certification as a Class C device under the European Union’s In Vitro Diagnostic Regulation (IVDR), becoming the first personalized MRD test for solid tumors to achieve... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.